Skip to content
MedsAcross

Medicine

Trezix 320.5 mg/30 mg/16 mg capsule

Available on requestPrescription onlyUS FDAControlled, schedule CIII

Trezix 320.5 mg/30 mg/16 mg capsule is a prescription medicine containing Acetaminophen, Caffeine and Dihydrocodeine for oral use, marketed by Proficient Rx, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.

Key facts

Active ingredient (INN)
Acetaminophen, Caffeine and Dihydrocodeine
Brand
Trezix
Strength
320.5 mg/30 mg/16 mg
Dosage form
Capsule
Route
Oral
Packs
100 capsules, 30 capsules, 60 capsules and 2 more
Marketing authorisation holder
Proficient Rx
Manufacturer
Proficient Rx
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F). Protect from moisture.
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Schedule CIII
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
1 December 2014
Identifiers
RxCUI 1190201, 1596108DailyMed set ID 45c3c2a1-6a89-471e-b6d4-5a4cd73b987aNDC 63187-705Application ANDA204785

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

PackCodeLabelerMarketed since
100 capsule in 1 bottle63187-705-00Proficient Rx1 June 2016
30 capsule in 1 bottle63187-705-30Proficient Rx1 June 2016
60 capsule in 1 bottle63187-705-60Proficient Rx1 June 2016
120 capsule in 1 bottle63187-705-72Proficient Rx1 August 2018
90 capsule in 1 bottle63187-705-90Proficient Rx1 June 2016

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAApprovedDrugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Clinical summary

Acetaminophen, Caffeine and Dihydrocodeine is a fixed-dose combination of a central nervous system stimulant, a methylxanthine and an opioid agonist indicated for the relief of moderate to moderately severe pain. MedsAcross supplies Acetaminophen, Caffeine and Dihydrocodeine for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Acetaminophen, Caffeine and Dihydrocodeine

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Trezix 320.5 mg/30 mg/16 mg capsule for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.